‘Earable’ technology a winner for CFT and Nokia

04 Nov, 2024
Newsdesk
Cambridge Future Tech (CFT) has partnered with Nokia Bell Labs and Nokia Ventures & Partnerships to establish OmniBuds Ltd – commercialising the world's first ear-worn AI/ML platform designed to monitor vital signs including heart and respiration rates, plus users’ physical activities and audio experiences.
Thumbnail
Courtesy – OmniBuds Ltd.

Venture builder, CFT aims to bring this disruptive tech to market, to accelerate its growth and drive significant change in the healthcare market globally.

It says the groundbreaking device is poised to revolutionise the health and wellness industry by providing continuous, real-time insights to care providers and enhancing patient care.

The technology behind the OmniBuds platform unlocks new ways to measure and manage health data, enabling earlier interventions, better decision making and improved outcomes – all leading to a better quality of life for users.

Billions of people around the world are already familiar with putting intelligent devices in or on their ears. The ear has long been targeted by researchers and companies alike as a window into the body for vital sign monitoring. The OmniBuds computing platform is a world-first, triggering a next generation in earable devices, says CFT.

CFT’s engagement with Nokia Bell Labs, the award-winning global industrial research arm of Nokia and birthplace of transformative technologies from the transistor to information theory, will ensure that the OmniBuds platform is poised for commercial success worldwide.

Owen Thompson, CEO and co-founder of Cambridge Future Tech said: “Partnering with an institution as prestigious as Nokia Bell Labs is a privilege. Their track record for pioneering innovation is unmatched, and we’re excited to collaborate to advance cutting-edge technologies. OmniBuds has the potential to completely transform the health tech space and positively impact people's lives around the world.”

Thierry E. Klein, President of Bell Labs Solutions Research at Nokia, added: “We are very privileged to engage with Cambridge Future Tech to commercialise the OmniBuds platform and create global impact through better health outcomes.

“We look to organisations like Cambridge Future Tech to accelerate the value creation from our research by taking our technology innovations out of the lab and putting them into the real-world.

“Nokia Bell Labs innovates with purpose to solve the most challenging industrial and societal problems. What could be more exciting than developing technologies to improve human health and well-being?”